PMC:7212236 / 0-437 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":45,"end":52},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":63,"end":71},"obj":"Disease"},{"id":"T2","span":{"begin":101,"end":109},"obj":"Disease"},{"id":"T3","span":{"begin":216,"end":240},"obj":"Disease"},{"id":"T4","span":{"begin":242,"end":250},"obj":"Disease"},{"id":"T5","span":{"begin":377,"end":385},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":260,"end":265},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T2","span":{"begin":269,"end":274},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T3","span":{"begin":289,"end":290},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":45,"end":52},"obj":"Chemical"},{"id":"T2","span":{"begin":53,"end":59},"obj":"Chemical"},{"id":"T3","span":{"begin":337,"end":342},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":73},"obj":"Sentence"},{"id":"T2","span":{"begin":75,"end":83},"obj":"Sentence"},{"id":"T3","span":{"begin":84,"end":96},"obj":"Sentence"},{"id":"T4","span":{"begin":97,"end":314},"obj":"Sentence"},{"id":"T5","span":{"begin":315,"end":388},"obj":"Sentence"},{"id":"T6","span":{"begin":390,"end":410},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}

{"project":"LitCovid-PubTator","denotations":[{"id":"9","span":{"begin":101,"end":111},"obj":"Species"},{"id":"10","span":{"begin":124,"end":133},"obj":"Species"},{"id":"11","span":{"begin":197,"end":203},"obj":"Species"},{"id":"12","span":{"begin":260,"end":265},"obj":"Species"},{"id":"13","span":{"begin":269,"end":274},"obj":"Species"},{"id":"14","span":{"begin":377,"end":387},"obj":"Species"},{"id":"15","span":{"begin":216,"end":240},"obj":"Disease"},{"id":"16","span":{"begin":242,"end":250},"obj":"Disease"},{"id":"17","span":{"begin":291,"end":300},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"Tax:2697049"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"Tax:2697049"},{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"Tax:9606"},{"id":"A12","pred":"tao:has_database_id","subj":"12","obj":"Tax:9606"},{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"Tax:9606"},{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Tax:2697049"},{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"MESH:C000657245"},{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"MESH:C000657245"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2\n\nAbstract\nIntroduction\nThe SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of \u003e 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.\n\nMaterial and methods\nState-of-the-art tools bas"}